Up-regulation of Melanin Synthesis by the Antidepressant Fluoxetine

Experimental Dermatology,

The results suggest that fluoxetine may hold a significant therapeutic potential for treating skin hypopigmentation disorders, and serotonin 1A receptor (SR1A) may serve as a novel target in modulating melanogenesis.

Print Article Summary Cat 2 CME Report